新洋豐(000902.SZ)擬5000萬元與姜任飛等對隆平生物進行增資擴股
格隆匯 2 月 8日丨新洋豐(000902.SZ)公佈,公司為進一步增強公司競爭優勢、佈局農業綜合服務,與袁隆平農業高科技股份有限公司(“隆平高科”)控股子公司隆平生物技術(海南)有限公司(“隆平生物”、“標的公司”)強強聯合,共同推進種、肥、藥一體化戰略合作及落地,持續提升自身盈利能力,擬使用自有資金5000萬元與姜任飛、湖州九碩股權投資合夥企業(有限合夥)對隆平生物進行增資擴股。此次增資完成後,隆平生物的註冊資本由5000萬元變更為5970萬元,增資後新洋豐的持股比例為8.38%。
此次對外投資是公司與隆平高科開展產業協同合作的探索,通過雙方產業運營優勢,建立種子和肥料市場渠道、客户資源的共享與協同機制,共同推進並強化種、肥、藥一體化戰略合作,有助於公司獲取轉基因玉米技術商業化的政策與產業的紅利,提升公司農業綜合服務能力,進一步增強公司在農資行業的競爭優勢,持續提升自身盈利水平。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.